US demand for cardiac implants will grow 8.8 percent annually through 2012, rebounding from a slowdown caused by product recalls and safety controversies. Pacing devices will remain the top-selling group, with gains led by CRT devices. Stents and accessories will be the fastest growing segment, driven by improved designs with reduced risk of complications.
This study analyzes the $10.7 billion US cardiac implant industry. It presents historical demand data for the years 1997, 2002 and 2007, and forecasts for 2012 and 2017 by implant type (e.g., ICDs, CRT devices, ICPs, pacing leads, coronary stents, peripheral stents, synthetic grafts, heart valves, ventricular-assist devices, implantable heart monitors); cardiovascular condition and implant procedure.
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 20 industry players, including Medtronic, Boston Scientific and St. Jude Medical.
